108 related articles for article (PubMed ID: 15148787)
1. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
Ando K; Ishikura R; Nagami Y; Morikawa T; Takada Y; Ikeda J; Nakao N; Matsumoto T; Arita N
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar; 64(3):121-6. PubMed ID: 15148787
[TBL] [Abstract][Full Text] [Related]
2. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
4. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
5. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
11. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
[TBL] [Abstract][Full Text] [Related]
12. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
Aydin H; Sipahioğlu S; Oktay NA; Altin E; Kizilgöz V; Hekimoglu B
JBR-BTR; 2011; 94(1):1-10. PubMed ID: 21466053
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
[TBL] [Abstract][Full Text] [Related]
16. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
[TBL] [Abstract][Full Text] [Related]
17. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
18. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
19. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
[TBL] [Abstract][Full Text] [Related]
20. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
